In early 2021, the Danish pharmaceutical company Novo Nordisk published a clinical trial showing remarkable results for semaglutide, now sold under the trade names Wegovy and Ozempic. Thomas Wadden, ...
Usage of weight loss medications including Glucagon-like peptide-1 receptor agonists such as Ozempic has skyrocketed in the U.S. in the last year, affecting numerous medical specialties. Here are ...